lactulose has been researched along with Fatty Liver, Nonalcoholic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Adali, G; Dogan, HO; Doganay, HL; Gokcen, P; Kara, H; Ozdil, K; Ozturk, O; Tosun, I; Yalman, Y | 1 |
| Atkins, AR; Downes, M; Evans, RM; Huan, T; Loomba, R; Madamba, E; Oh, TG; Sharpton, SR; Wang, C; Yu, RT | 1 |
| Akahane, T; Enomoto, M; Fujimoto, Y; Fujinaga, Y; Inoue, T; Kaji, K; Kawaratani, H; Kitagawa, K; Mitoro, A; Moriya, K; Murata, K; Namisaki, T; Nishimura, N; Sawada, Y; Takaya, H; Takeda, S; Tsuji, Y; Yoshiji, H | 1 |
| Lukashevich, AP; Lyapina, MV; Vakhrushev, YM | 1 |
| Eder, MD; Hosseini, R; Kravetz, JD; Thomas, A; Varma, P | 1 |
| Faccioli, J; Gioia, S; Nardelli, S; Ridola, L; Riggio, O | 1 |
| Cheng, Y; Dai, F; Mao, L; Quan, X; Shi, H; Wang, L; Xu, X; Zhu, S | 1 |
| Flamm, SL | 1 |
| Alisi, A; Ferretti, F; Giorgio, V; Grieco, A; Miele, L; Negro, V; Nobili, V; Principessa, L; Villa, MP | 1 |
2 review(s) available for lactulose and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Clinical management of type C hepatic encephalopathy.
Topics: Administration, Oral; Anti-Bacterial Agents; Drug Therapy, Combination; Endovascular Procedures; Enema; Hepatic Encephalopathy; Hepatic Veins; Humans; Imaging, Three-Dimensional; Lactulose; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Portal Vein; Prevalence; Psychometrics; Rifaximin; Severity of Illness Index; Stents; Tomography, X-Ray Computed; Urinary Tract Infections | 2020 |
Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP.
Topics: Anti-Bacterial Agents; Carcinoma, Hepatocellular; Early Detection of Cancer; Education, Medical, Continuing; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Practice Guidelines as Topic; Prevalence; Primary Health Care; Risk Factors; United States | 2017 |
7 other study(ies) available for lactulose and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
A novel therapeutic approach to NASH: Both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL/6J mice.
Topics: Animals; Inflammation; Lactulose; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Polyethylene Glycols; Prospective Studies | 2021 |
Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis.
Topics: Adult; Ascites; End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Metagenome; Non-alcoholic Fatty Liver Disease; Prospective Studies; Rifaximin; Severity of Illness Index | 2022 |
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib.
Topics: Albumins; Bilirubin; Carcinoma, Hepatocellular; Humans; Lactulose; Liver Diseases, Alcoholic; Liver Neoplasms; Mannitol; Non-alcoholic Fatty Liver Disease; Phenylurea Compounds; Quinolines | 2022 |
[The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bacteria; Humans; Hydrogen; Intestine, Small; Lactulose; Microbiota; Non-alcoholic Fatty Liver Disease | 2022 |
A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis.
Topics: Aged; Brain; Confusion; Dyskinesias; Esophageal and Gastric Varices; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Hyperbilirubinemia; Hypertension, Portal; Lactulose; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Non-alcoholic Fatty Liver Disease; Renal Veins; Rifaximin; Splenic Vein; Thrombocytopenia; Tomography, X-Ray Computed; Tremor; Vascular Diseases | 2020 |
Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease.
Topics: Breath Tests; Endotoxins; Gastrointestinal Transit; Humans; Intestine, Small; Lactulose; Non-alcoholic Fatty Liver Disease | 2021 |
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity.
Topics: Adolescent; Bacterial Translocation; Case-Control Studies; Child; Female; Humans; Intestinal Mucosa; Lactulose; Lipopolysaccharides; Male; Mannitol; Non-alcoholic Fatty Liver Disease; Permeability; Severity of Illness Index | 2014 |